Showing results (151-160 of 4,360) with videos related to
Sort By:
Pageof 436
Journal of Molecular Neuroscience : MN|June 8, 2004
Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer's diseaseLorenzo M Refolo, Howard M FillitJournal of Molecular Neuroscience : MN|June 8, 2004
Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's diseaseYadong Huang, Karl H Weisgraber, Lennart Mucke, et al.Journal of Molecular Neuroscience : MN|June 8, 2004
Cholesterol efflux as a critical component of Alzheimer's disease pathogenesisG William RebeckJournal of Molecular Neuroscience : MN|May 6, 2004
Current concepts and controversies in prion immunopathologyMathias Heikenwalder, Marco Prinz, Frank L Heppner, et al.Journal of Molecular Neuroscience : MN|May 6, 2004
Cell degeneration induced by amyloid-beta peptides: implications for Alzheimer's diseaseCláudia Pereira, Elisabete Ferreiro, Sandra Morais Cardoso, et al.Journal of Molecular Neuroscience : MN|May 6, 2004
Signal transduction therapeutics: relevance for Alzheimer's diseaseOdete A B da Cruz e Silva, Margarida Fardilha, Ana Gabriela Henriques, et al.Journal of Molecular Neuroscience : MN|May 6, 2004
Mild cognitive impairment: focus on diagnosisAlexandre de Mendonça, Manuela Guerreiro, Filipa Ribeiro, et al.Journal of Molecular Neuroscience : MN|January 27, 2004
Neprilysin regulates amyloid Beta peptide levelsRobert A Marr, Hanjun Guan, Edward Rockenstein, et al.Journal of Molecular Neuroscience : MN|January 27, 2004
Overexpression of human cystatin C in transgenic mice does not affect levels of endogenous brain amyloid Beta PeptideMonika Pawlik, Magdalena Sastre, Miguel Calero, et al.Journal of Molecular Neuroscience : MN|January 27, 2004
NCAM mimetic peptides: Pharmacological and therapeutic potentialVladimir Berezin, Elisabeth BockPageof 436